Summary: Psychedelic Times reviews Psychedelic Science Summit 2019, an educational conference about psychedelics hosted by MAPS that took place in Austin, Texas, from November 1-3, 2019. Author Wesley …
Summary: Psychology Compass compiles a comprehensive review of key findings from psychedelic research that spans historical psychedelic research to current clinical trials.The evolving guide is updated …
Summary: Research into the potential benefit of psychedelics to increase well-being in the lives of those who are not experiencing mental health conditions is explored in an article from Elemental, which …
Summary: “MAPS sets a high standard for other psychedelic institutions, not just by way of their achievements in research, but by their desire to educate the public in an inclusive way that avoids …
Summary: Scientific data on older people using ayahuasca is elusive but anecdotal evidence is growing,” explains The New York Times in a piece that features insights from senior citizens who participate …
Summary: Marijuana Moment highlights the findings of a paper published in the Journal of Psychiatric Practice that found psychedelics can potentially reduce symptoms associated with at least eight psychiatric …
Summary: Wolters Kluwer Health expands upon a literature review in the Journal of Psychiatric Practice that investigated a growing body of evidence demonstrating how psychedelics may be beneficial for …
Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., is profiled by Boston Magazine in a dynamic interview that touches on the progress of clinical trials of MDMA-assisted psychotherapy for …
Summary: Frank151 interviews Brad Burge of MAPS to learn more about MAPS-sponsored psychedelic research, the goals of MAPS over the next few years, and the potential benefits of psychedelic therapy for …
Summary: Inside Eyes Podcast interviews Ismail Ali, J.D., of MAPS and drug policy expert Jag Davies about psychedelic medicine. In this episode, they explore answers around access to psychedelic therapy …
Summary: The Los Angeles Times reports on the catalyst and inspiration that helped formed the group Decriminalize Nature Oakland, which wrote the ordinance to decriminalize psychedelic plants in Oakland, …
Summary: In a letter responding to U.S. Senator Brian Schatz’s (D-HI) inquiries regarding the government’s plans on investigating the medicinal value of psychedelics, the Food and Drug Administration …
